Human interferon-beta formulations
The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN 1 b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides s...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | McCaman, Michael Ottoboni, Susanne Pungor, Erno |
| description | The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN
1
b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN- lyophilizates prepared from biologically active IFN- , dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20030118548</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20030118548</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200301185483</originalsourceid><addsrcrecordid>eNrjZFDyKM1NzFPIzCtJLUpLLcrP001KLUlUSMsvyi3NSSzJzM8r5mFgTUvMKU7lhdLcDJpuriHOHrqlxQWJJal5JcXxiQUFOZnJEOXxRgYGxgaGhhamJhbGpKgFANz7LXo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Human interferon-beta formulations</title><source>USPTO Published Applications</source><creator>McCaman, Michael ; Ottoboni, Susanne ; Pungor, Erno</creator><creatorcontrib>McCaman, Michael ; Ottoboni, Susanne ; Pungor, Erno</creatorcontrib><description>The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN
1
b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN- lyophilizates prepared from biologically active IFN- , dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20030118548$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,873,885,64059</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10190838$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>McCaman, Michael</creatorcontrib><creatorcontrib>Ottoboni, Susanne</creatorcontrib><creatorcontrib>Pungor, Erno</creatorcontrib><title>Human interferon-beta formulations</title><description>The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN
1
b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN- lyophilizates prepared from biologically active IFN- , dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZFDyKM1NzFPIzCtJLUpLLcrP001KLUlUSMsvyi3NSSzJzM8r5mFgTUvMKU7lhdLcDJpuriHOHrqlxQWJJal5JcXxiQUFOZnJEOXxRgYGxgaGhhamJhbGpKgFANz7LXo</recordid><startdate>20030626</startdate><enddate>20030626</enddate><creator>McCaman, Michael</creator><creator>Ottoboni, Susanne</creator><creator>Pungor, Erno</creator><scope>EFI</scope></search><sort><creationdate>20030626</creationdate><title>Human interferon-beta formulations</title><author>McCaman, Michael ; Ottoboni, Susanne ; Pungor, Erno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200301185483</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>McCaman, Michael</creatorcontrib><creatorcontrib>Ottoboni, Susanne</creatorcontrib><creatorcontrib>Pungor, Erno</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>McCaman, Michael</au><au>Ottoboni, Susanne</au><au>Pungor, Erno</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Human interferon-beta formulations</title><date>2003-06-26</date><risdate>2003</risdate><abstract>The invention provides a stable pharmaceutical composition containing biologically active human interferon- (IFN- ), preferably IFN
1
b produced in a bacterial host, dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0. The invention of also provides stable IFN- lyophilizates prepared from biologically active IFN- , dissolved in an aqueous-based solution containing a glycine buffer at a pH of about 2.0 to about 4.0.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_applications_20030118548 |
| source | USPTO Published Applications |
| title | Human interferon-beta formulations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T01%3A08%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=McCaman,%20Michael&rft.date=2003-06-26&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20030118548%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |